麻豆传媒

The 2018 ALS Project Grant Program encompasses applications previously designated for Discovery, Bridge or Clinical Management Grant competitions. The purpose of the program is to invest in the best possible projects that are i) novel research approaches, supported by sound rationale and a feasible experimental plan, but not necessarily preliminary data, ii) part of an ongoing ALS research program, and aimed toward the vision of ALS Canada, which is 鈥淎 future without ALS鈥� or iii) research focused on avenues to maximize function, minimize disability and optimize quality of life through symptom management, and support to families and persons or families living with ALS. Examples include, but are not limited to, management of secretions and cramps, psychological interventions to address mental health issues, nutritional interventions, respiratory care, engineering applications to reduce physical limitations, and programs to address the needs of caregivers.

Funding:

Up to eight awards of up to $125,000 will be awarded in this cycle. The one time award may be used for research over a 12-24 month period, at the discretion of the Principal Investigator (PI).

Eligibility:

In applications involving multiple institutions and/or investigations, a lead investigator must be named who will assume the administrative and financial responsibility for the grant, which will be paid to that individual鈥檚 institution (the Institution Paid).

In the event that the PI does not hold an academic position, justification must be provided for assessment by an ad hoc sub-committee of the Scientific and Medical Advisory Council.

For full program details and eligibility requirements please visit the .听

Please direct your questions to christine.whitehouse@dal.ca听 or听david.spurrell@dal.ca

Internal Deadline: June 01, 2018
Agency Deadline: June 08, 2018

听